These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 5286773)

  • 1. Comparison of methylperidol and trifluoperazine in the treatment of chronic, underactive schizophrenic patients.
    Jones IH; Davies J; Buckle R; Hanna WH; Pikler N
    Aust N Z J Psychiatry; 1970 Sep; 4(3):143-7. PubMed ID: 5286773
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of two butyrophenones with trifluoperazine.
    Marjerrison G; Hrychuk W; Varsanyi EI
    Can Psychiatr Assoc J; 1966 Feb; 11(1):26-30. PubMed ID: 5322990
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of trifluoperazine and molindone in chronic schizophrenic patients.
    Freeman H; Frederick AN
    Curr Ther Res Clin Exp; 1969 Nov; 11(11):670-6. PubMed ID: 4982301
    [No Abstract]   [Full Text] [Related]  

  • 4. Thiothixene in schizophrenic psychoses.
    Vinar O; Taussigová D; Bastecký J
    Act Nerv Super (Praha); 1971; 13(3):174-7. PubMed ID: 4939830
    [No Abstract]   [Full Text] [Related]  

  • 5. A pilot study of AL-1021 in chronic schizophrenic patients.
    Sugerman AA
    Curr Ther Res Clin Exp; 1969 Dec; 11(12):775-8. PubMed ID: 4984042
    [No Abstract]   [Full Text] [Related]  

  • 6. A double-blind comparison of trifluperidol and trifluoperazine in acute schizophrenic patients.
    Schiele BC; Janecek J; Zimmermann R
    Compr Psychiatry; 1969 Sep; 10(5):355-60. PubMed ID: 4389944
    [No Abstract]   [Full Text] [Related]  

  • 7. An early clinical trial of lenperone (AHR 2277), a butyrophenone, in chronic schizophrenia.
    Simpson GM; Varga V
    Curr Ther Res Clin Exp; 1974 May; 16(5):477-82. PubMed ID: 4209063
    [No Abstract]   [Full Text] [Related]  

  • 8. Pilot study on the use of AL-1021 in the treatment of chronic schizophrenia.
    Angus JW; Go SH; Simpson GM
    Curr Ther Res Clin Exp; 1969 Dec; 11(12):779-83. PubMed ID: 4984043
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of the effects of oxypertine and trifluoperazine in withdrawn schizophrenics.
    Hunt PV
    Br J Psychiatry; 1967 Dec; 113(505):1419-24. PubMed ID: 4865294
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychopharmacologic characteristics of an indole compound--molindone.
    Claghorn JL
    Curr Ther Res Clin Exp; 1969 Aug; 11(8):524-7. PubMed ID: 4979704
    [No Abstract]   [Full Text] [Related]  

  • 11. Relation of hypermagnesaemia to activity and neuroleptic drug therapy in schizophrenic states.
    Brackenridge CJ; Jones IH
    J Neurol Neurosurg Psychiatry; 1971 Apr; 34(2):195-9. PubMed ID: 5571604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical effects of intramuscular thiothixene and trifluoperazine in chronic schizophrenia: a comparative study.
    Holden JM; Itil TM; Gannon PJ; Keskiner A
    Curr Ther Res Clin Exp; 1971 May; 13(5):298-310. PubMed ID: 4998393
    [No Abstract]   [Full Text] [Related]  

  • 13. Flupenthixol and trifluoperazine: a double-blind investigation in the treatment of schizophrenics.
    Gottfries CG
    Br J Psychiatry; 1971 Nov; 119(552):547-8. PubMed ID: 4944664
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical evaluation of a butyrophenone derivative, methylperidol, in 40 cases of schizophrenia and other psychoses].
    Vinci M
    Osp Psichiatr; 1971; 39(2):399-407. PubMed ID: 4948707
    [No Abstract]   [Full Text] [Related]  

  • 15. Thiothixene versus trifluoperazine in newly-admitted schizophrenic patients.
    Bishop MP; Fulmer TE; Gallant DM
    Curr Ther Res Clin Exp; 1966 Nov; 8(11):509-14. PubMed ID: 4962777
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the clinical and electroencephalographical effects of molindone and trifluoperazine in acute schizophrenic patients.
    Itil TM; Polvan N; Ucok A; Eper E; Güven F; Hsu W
    Behav Neuropsychiatry; 1971; 3(5):25-32. PubMed ID: 4948596
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined pharmacotherapy and psychotherapy.
    Uhlenhuth EH; Lipman RS; Covi L
    J Nerv Ment Dis; 1969 Jan; 148(1):52-64. PubMed ID: 4388798
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of pimozide with perphenazine in the treatment of acute schizophrenic psychoses.
    Svestka J; Náhunek K
    Act Nerv Super (Praha); 1972; 14(2):93-4. PubMed ID: 4557145
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of trifluperidol, trifluoperazine and chlorpromazine in preschool schizophrenic children: the value of less sedative antipsychotic agents.
    Fish B; Campbell M; Shapiro T; Floyd A
    Curr Ther Res Clin Exp; 1969 Oct; 11(10):589-95. PubMed ID: 4981301
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative study of trifluperidol and trifluoperazine in the treatment of acute schizophrenia].
    Gauthier R; Hillel J; Bordeleau JM; Tétreault L
    Union Med Can; 1967 Aug; 96(8):936-43. PubMed ID: 5618135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.